Past Webinar Investigation in Rheumatology Expert Talk on Tofacitinib: Choosing the right patients – Balancing Safety and Efficacy by Dr. Chandrashekara. S Read More » Grey Areas in Rheumatology – Session:5- Perioperative management of biologics by Dr. Prakruthi Jaladhar Read More » Grey Areas in Rheumatology – Session:4- Vaccination during Immunosuppression by Dr. Ashwini Kamath Read More » Grey Areas in Rheumatology – Session:3- Seronegative RA: Diagnostic Certainty and Treatment by Dr. Shivaputrappa Ghanti Read More » Grey Areas in Rheumatology – Session 1, Topic: ANA Positive: When should we treat? by Dr. Mukhtar Ahmad Masoodi Read More » Grey Areas in Rheumatology – Session 2, Topic: Positive ANA: When should we investigate further? by Dr. Utkarsha Patil Read More » Page1 Page2 Page3 Page4 Page5 Other Webinar Expert Talk on Tofacitinib: Choosing the right patients – Balancing Safety and Efficacy by Dr. Chandrashekara. S Read More » Grey Areas in Rheumatology – Session:5- Perioperative management of biologics by Dr. Prakruthi Jaladhar Read More » Grey Areas in Rheumatology – Session:4- Vaccination during Immunosuppression by Dr. Ashwini Kamath Read More » Grey Areas in Rheumatology – Session:3- Seronegative RA: Diagnostic Certainty and Treatment by Dr. Shivaputrappa Ghanti Read More » Grey Areas in Rheumatology – Session 1, Topic: ANA Positive: When should we treat? by Dr. Mukhtar Ahmad Masoodi Read More » Grey Areas in Rheumatology – Session 2, Topic: Positive ANA: When should we investigate further? by Dr. Utkarsha Patil Read More » Page1 Page2 Page3 Page4 Page5
Expert Talk on Tofacitinib: Choosing the right patients – Balancing Safety and Efficacy by Dr. Chandrashekara. S Read More »
Grey Areas in Rheumatology – Session:5- Perioperative management of biologics by Dr. Prakruthi Jaladhar Read More »
Grey Areas in Rheumatology – Session:4- Vaccination during Immunosuppression by Dr. Ashwini Kamath Read More »
Grey Areas in Rheumatology – Session:3- Seronegative RA: Diagnostic Certainty and Treatment by Dr. Shivaputrappa Ghanti Read More »
Grey Areas in Rheumatology – Session 1, Topic: ANA Positive: When should we treat? by Dr. Mukhtar Ahmad Masoodi Read More »
Grey Areas in Rheumatology – Session 2, Topic: Positive ANA: When should we investigate further? by Dr. Utkarsha Patil Read More »
Expert Talk on Tofacitinib: Choosing the right patients – Balancing Safety and Efficacy by Dr. Chandrashekara. S Read More »
Grey Areas in Rheumatology – Session:5- Perioperative management of biologics by Dr. Prakruthi Jaladhar Read More »
Grey Areas in Rheumatology – Session:4- Vaccination during Immunosuppression by Dr. Ashwini Kamath Read More »
Grey Areas in Rheumatology – Session:3- Seronegative RA: Diagnostic Certainty and Treatment by Dr. Shivaputrappa Ghanti Read More »
Grey Areas in Rheumatology – Session 1, Topic: ANA Positive: When should we treat? by Dr. Mukhtar Ahmad Masoodi Read More »
Grey Areas in Rheumatology – Session 2, Topic: Positive ANA: When should we investigate further? by Dr. Utkarsha Patil Read More »
